Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do people with diabetes need statins?

John R White1

  • 1Department of Pharmacotherapy, Washington State University Spokane, Spokane, WA 99202, USA. whitej@wsu.edu

The Diabetes Educator
|August 2, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetic Evaluation of a Cinnamon Product on CYP2A6 Substrate Drugs: Application of a Novel Tool Involving the Nicotine Metabolite Ratio.

Clinical pharmacology and therapeutics·2026
Same author

Wind-driven shear stress on sediment phosphorus release: Implications for water quality, and harmful algal blooms in a shallow estuary.

The Science of the total environment·2025
Same author

Legacy phosphorus dynamics in subtropical river sediments: Impacts of dredging and water column aeration status.

Journal of environmental quality·2025
Same author

Implications of river reconnection on phosphorus cycling in coastal wetlands.

The Science of the total environment·2025
Same author

On the calculation of carbon and nutrient transport to the oceans.

Scientific reports·2025
Same author

The Pharmacokinetic Interaction Between Metformin and the Natural Product Goldenseal Is Metformin Dose-Dependent: A Three-Arm Crossover Study in Adults With Type 2 Diabetes.

Clinical and translational science·2025
Same journal

Correction to 'Competencies for Diabetes Care and Education Specialists' by Ryan et al. <i>The Diabetes Educator</i> 46(4), pages 384-397 (August 2020).

The Diabetes educator·2020
Same journal

<i>The Diabetes Educator</i> (<i>TDE</i>): Successes, Opportunities, and Future Changes.

The Diabetes educator·2020
Same journal

An Umbrella Review of Text Message Programs for Adults With Type 2 Diabetes.

The Diabetes educator·2020
Same journal

Community-Based Participatory Research Interventions to Improve Diabetes Outcomes: A Systematic Review.

The Diabetes educator·2020
Same journal

"Together We Can Return to Balance"-Eastern Woodlands Native Perspectives and Type 2 Diabetes: A Qualitative Study.

The Diabetes educator·2020
Same journal

The Healthy Eating and Living Against Noncommunicable Diseases Study: An Innovative Family-Based Intervention.

The Diabetes educator·2020
See all related articles

Intensive statin therapy significantly reduces cardiovascular disease (CVD) risk by approximately 25% in patients with type 2 diabetes mellitus. This treatment is recommended for most diabetic patients, even those with normal cholesterol levels, to manage dyslipidemia and improve outcomes.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Background:

  • Type 2 diabetes mellitus (T2DM) prevalence is rapidly increasing globally.
  • Individuals with T2DM have double the absolute risk of cardiovascular disease (CVD) compared to non-diabetics.
  • A significant number of diabetic patients experience fatal cardiovascular events before hospital admission.

Purpose of the Study:

  • To evaluate the efficacy of intensive statin therapy in managing diabetic dyslipidemia and reducing CVD risk.
  • To determine if statin therapy is beneficial even when low-density lipoprotein cholesterol (LDL-C) is not markedly elevated.

Main Methods:

  • Analysis of data from randomized, controlled clinical trials on statin therapy in diabetic patients.
  • Assessment of statin therapy's impact on CVD risk reduction, LDL-C, triglyceride, and high-density lipoprotein cholesterol levels.

Related Experiment Videos

Main Results:

  • Intensive statin therapy demonstrated relative reductions in CVD risk of approximately 25% in diabetic populations.
  • Statins effectively achieve recommended LDL-C goals in diabetic patients, irrespective of baseline LDL-C levels.
  • Statins, alone or combined with other lipid-lowering drugs, can improve triglyceride and HDL-C abnormalities.

Conclusions:

  • Intensive statin therapy is warranted for most patients with T2DM or T2DM and established CVD.
  • Statin therapy is a cornerstone in managing cardiovascular risk in diabetic patients by optimizing lipid profiles.
  • Early and consistent statin use can mitigate the disproportionately high CVD burden in individuals with diabetes.